Air Pollution and Development in the Boricua Youth Study
Launched by NEW YORK STATE PSYCHIATRIC INSTITUTE · May 5, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The NYSPI site is currently paused and has been paused since an institutional pause on human subjects research began in June, 2023.
The U.S. Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP) issued an FWA restriction on NYSPI research that also included a pause of human subjects research as of June 23, 2023.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been enrolled in the BYS-ECHO birth cohort (parent study).
- • Speaks English or Spanish.
- • Having a parent that is eligible to participate, based on criterial detailed below, and agrees to participation.
- • One parent must speak English or Spanish.
- Exclusion Criteria:
- • Having serious neurological disorder, excluding ASD (e.g., seizure disorder).
- • MRI contraindications (irremovable metal in body like braces, pacemakers).
- • Claustrophobia.
- • Having a parent that is not competent to consent (e.g., severe intellectual disability would have triggered exclusion) or under 18 years of age.
About New York State Psychiatric Institute
The New York State Psychiatric Institute (NYSPI) is a leading research organization dedicated to advancing the understanding and treatment of mental health disorders. Affiliated with Columbia University, NYSPI integrates clinical research with cutting-edge scientific inquiry to develop innovative therapeutic strategies and improve patient care. With a focus on a wide range of psychiatric conditions, NYSPI conducts clinical trials that aim to translate findings from laboratory research into effective interventions, enhancing the quality of life for individuals affected by mental illness. Committed to ethical research practices and collaboration, NYSPI plays a pivotal role in shaping the future of psychiatric care through rigorous scientific exploration and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Claudia I Lugo-Candelas, PhD
Principal Investigator
Columbia University Irving Medical Center/New York State Psychiatric institute
Glorisa Canino, PhD
Principal Investigator
University of Puerto Rico
Cristiane S Duarte, PhD
Principal Investigator
Columbia University Irving Medical Center/New York State Psychiatric institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials